 帝京大学薬学部 |
研究室ページ | English | ||
| 医薬品作用学研究室 | |||
|
|
|||
 |
論文リスト | ||
1. |
Mori A, Ezawa Y, Asano D, Kanamori T, Morita A, Kashihara T, Sakamoto K, Nakahara T. Resveratrol dilates arterioles and protects against N-methyl-D-aspartic acid-induced excitotoxicity in the rat retina. Neurosci Lett. 793: 136999 (2023) | ||
2. |
森 麻美 ラット網膜における神経‐グリア細胞を介する血管拡張機序 ファルマシア Vol. 58 (11) P1021-1025 (2022) | ||
3. |
Kamiya E, Morita A, Mori A, Sakamoto K, Nakahara T. The process of methylglyoxal-induced retinal capillary endothelial cell degeneration in rats. Microvasc Res. 146:104455 (2022) | ||
4. |
Mori A, Seki H, Mizukoshi S, Uezono T, Sakamoto K. Role of prostaglandins in nitric oxide-induced glial cell-mediated vasodilation in rat retina. Biomolecules. 12(10): 1403 (2022) | ||
5. |
森田 茜，菅原 志央吏，入田 孟大，柏原 俊英，森 麻美，坂本 謙司，中原 努 VEGF 受容体阻害薬を用いた新生仔マウス新規網膜以上血管新生モデル 眼薬理 36(.1): P76-78, (2022) | ||
6. |
Nagaoka K, Kurauchi Y, Asano D, Morita A, Sakamoto K, Nakahara T. Pharmacological inhibition of Na+/K+-ATPase induces neurovascular degeneration and glial cell alteration in the rat retina. Exp Eye Res. 220:109107. (2022) | ||
7. |
Aimoto M, Yagi K, Ezawa A, Tsuneoka Y, Kumada K, Hasegawa T, Kuze T, Chiba T, Nagasawa Y, Tanaka H, Takahara A. Chronic volume overload caused by abdominal aorto-venocaval shunt provides arrhythmogenic substrates in the rat atrium. Biol Pharm Bull. 45(5):635-642 (2022) | ||
8. |
Mori A, Sumida D, Kondo R, Nakano A, Arima S, Asano D, Morita A, Sakamoto K, Nagamitsu T, Nakahara T. Impairment of endothelium-dependent vasodilator function of retinal blood vessels in adult rats with a history of retinopathy of prematurity. J Pharmacol Sci., 146(4), 233-243 (2021). | ||
9. |
Watanabe K, Asano D, Ushikubo H, Morita A, Mori A, Sakamoto K, Ishii K, Nakahara T. Metformin Protects against NMDA-Induced Retinal Injury through the MEK/ERK Signaling Pathway in Rats., Int J Mol Sci., 22(9), 4439 (2021). | ||
10. |
Morita A, Yoshizumi M, Arima S, Mori A, Sakamoto K, Nagamitsu T, Nakahara T. Pharmacological depletion of retinal neurons prevents vertical angiogenic sprouting without affecting the superficial vascular plexus. Dev Dyn., 250(4), 497-512 (2021). | ||
11. |
Mori A, Takei T, Suzuki N, Sakamoto K, Morita M, Nakagawa S, Nakahara T, Ishii K. L-Citrulline ameliorates the attenuation of acetylcholine-induced vasodilation of retinal arterioles in diabetic rats. Heliyon, 7(3), e06532 (2021). | ||
12. |
Mori A, Namekawa R, Sakamoto K, Ishii K, Nakahara T. Involvement of Gap Junctions in Acetylcholine-Induced Endothelium-Derived Hyperpolarization-Type Dilation of Retinal Arterioles in Rats. Biol Pharm Bull., 44(12), 1860-1865 (2021). | ||
13. |
Mori A, Yano E, Sakamoto K, Ishii K, Nakahara T. Role of Epoxyeicosatrienoic Acids in Acetylcholine-Induced Dilation of Rat Retinal Arterioles in Vivo. Biol Pharm Bul, 44(1), 82-87 (2021). | ||
14. |
Morita A, Goko T, Matsumura M, Asaso D, Arima S, Mori A, Sakamoto K, Nagamitsu T, Nakahara T. The process of revascularization in the neonatal mouse retina following short-term blockade of vascular endothelial growth factor receptors. Cell Tissue Res., 82(3), 529-549 (2020). | ||
15. |
Mori A, Taniai A, Hasegawa M, Sakamoto K, Nakahara T. Involvement of Gi protein-dependent BKCa channel activation in Beta2-adrenoceptor-mediated dilation of retinal arterioles in rats. Naunyn Schmiedebergs Arch Pharmacol., 393(11), 2043-2052 (2020). | ||
16. |
網膜変性疾患におけるmicroRNAの発現変動；坂本 謙司, 浅野 大樹, 森田 茜, 森 麻美, 中原 努; 日本薬理学雑誌 2020;155(2), 81-86 (2020) | ||
17. |
Changes in components of the neurovascular unit in the retina in a rat model of retinopathy of prematurity.; Nakano A, Kondo R, Kaneko Y, Arima S, Asano D, Morita A, Sakamoto K, Nagamitsu T, Nakahara T.; Cell Tissue Res. 379(3), 473-486 (2020) | ||
18. |
Activation of transient receptor potential vanilloid 4 channels dilates rat retinal arterioles through nitric oxide- and BKCa channel-dependent mechanisms in vivo. ; Mori A, Takeda K, Sakamoto K, Nakahara T.Naunyn Schmiedebergs Arch Pharmacol., 393(1), 35-41 (2020) | ||
19. |
Attenuation of Retinal Endothelial Vasodilator Function in a Rat Model of Retinopathy of Prematurity.; Nakano A, Mori A, Arima S, Asano D, Morita A, Sakamoto K, Nagamitsu T, Nakahara T.; Curr Eye Res., 44(12), 1360-1368 (2019) | ||
20. |
Role of Neuron?Glia Signaling in Regulation of Retinal Vascular Tone in Rats.;Someya E, Akagawa M, Mori A, Morita A, Yui N, Asano D, Sakamoto K, Nakahara T.;Int J Mol Sci.; 20(8), pii: E1952 (2019) | ||
21. |
Involvement of matrix metalloproteinases in capillary degeneration following NMDA-induced neurotoxicity in the neonatal rat retina.; Asano D, Morita A, Mori A, Sakamoto K, Ishii K, Nakahara T.; Exp Eye Res., 182, 101-108 (2019) | ||
22. |
Probucol Slows the Progression of Cataracts in Streptozotocin-Induced Hyperglycemic Rats.;Higashi K, Mori A, Sakamoto K, Ishii K, Nakahara T.;Pharmacology., 103(3-4), 212-219 (2019) | ||
23. |
Enhancement or suppression of ACE inhibitory activity by a mixture of tea and foods for specified health uses (FOSHU) that are marketed as "support for normal blood pressure"; Murakami, I., Hosono, H., Suzuki, S., Kurihara, J., Itagaki, F. and Watanabe, M.; ISRN Pharmaceutics, Article ID712196, 1-4 (2011) | ||
24. |
帝京大学薬学部における小児科外来実習でのアンケートを用いた医療面接実習の有用性の評価; 齋藤百枝美、中島康雄、小佐野博史、栗原順一、渡邊真知子、藤井靖史、 柳川幸重、山岡桂子、井上圭三; Jpn.J.Pharm.Health Care Sci. 33(9),741-747 (2007) |
||
25. |
Captopril enhances cardiac vagal but not sympathetic neurotransmission in pithed rats. ; Takata Y, Arai T, Suzuki S, Kurihara J, Uezono T, Okubo Y, Kato H. : J Pharmacol Sci. 95(3) 390-3 (2004) | ||
26. |
Ischemic preconditioning affects the subcellular distribution of protein kinase C and calcium/calmodulin-dependent protein kinase II in the gerbil hippocampal CA1 neurons; Katsura, K., Kurihara, J., Kato, H, and Katayama, Y.: Neurol. Res. 23(7) 751−754 (2001) | ||
27. |
2-Arachidonoylglycerol and anandamide oppositely modulate norepinephrine release from the rat heart sympathetic nerves; Kurihara, J., Nishigaki, M., Suzuki, S., Okubo, Y., Takata, Y., Nakane, S., Sugiura, T., Waku, K. and Kato, H.: Jpn. J. Pharmacol. 87(1) 93−96 (2001) | ||
28. |
KT3-671, an angiotensin AT1 receptor antagonist, attenuates vascular but not cardiac responses to sympathetic nerve stimulation in pithed rats ; Takata, Y., Kurihara, J., Yoda, T., Suzuki, S., Matsuoka, Y., Okubo, Y. and Kato, H.: J. Cardiovasc. Pharmacol. 37(4) 427−436 (2001) | ||
29. |
ウサギにおける抗精神病薬誘発性起立性低血圧に対するmidodrineの作用 ; 高田芳伸, 栗原順一, 鈴木重人, 大久保陽子, 加藤仁 : 薬理と治療 28(12) 1023−1035 (2000) |
||
30. |
Effect of midodrine on chlorpromazine-induced orthostatic hypotension in rabbit: Comparison with amezinium, etilefrine and droxidopa ; Kurihara, J., Takata, Y., Suzuki, S., Okubo, Y. and Kato, H.: Biol. Pharm. Bull. 23(12) 1445−1449 (2000) |
||
31. |
Inhibitory effect of KT3-671, a nonpeptide angiotensin subtype 1 receptor antagonist, on sympathetic neurotransmission in isolated rabbit aorta ; Takata, Y., Tajima, S. and Kato, H.: Pharmacol. Res. 41(3) 335−340 (2000) | ||
32. |
A rabbit model for evaluation of chlorpromazine-induced orthostatic hypotension ; Takata, Y., Kurihara, J., Suzuki, S., Okubo, Y. and Kato, H.: Biol. Pharm. Bull. 22(5) 457−462 (1999) | ||
33. |
Antihypertensive activity and pharmacokinetics of KD3-671, a nonpeptide AT1 receptor antagonist, in renal hypertensive dogs ; Takata, Y., Tajima, S., Mochizuki, S., Suzaka, H., Tomiyama, A. and Kato, H.: J. Cardiovasc. Pharmacol. 32(5) 834−844 (1998) | ||
34. |
腎性高血圧犬に連続経口投与した新規Ca拮抗薬シルニジピンの抗高血圧作用 ; 高原章, 内田裕久, 今田智之, 堂本英樹, 吉元良太, 小森美幸, 森岡朋子, 小野一郎, 高田芳伸, 加藤仁 : 日本薬理学雑誌 106(4) 279−287 (1995) |
||
35. |
Inhibitory effect of cilnidipine on vascular sympathetic neurotransmission and subsequent vasoconstriction in spontaneously hypertensive rats ; Hosono, M., Fujii, S. Hiruma, T., Watanabe, K., Hayashi, Y., Ohnishi, H., Takata, Y. and Kato, H: Jpn. J. Pharmacol. 69(2) 127−134 (1995) |
||
36. |
Inhibitory effect of cilnidipine on pressor response to acute cold stress in spontaneously hypertensive rats ; Hosono, M., Hiruma, T., Watanabe, K., Hayashi, Y., Ohnishi, H., Takata, Y. and Kato, H.: Jpn. J. Pharmacol. 69(2) 119−125 (1995) | ||
37. |
高分子ヒアルロン酸ナトリウム(NRD101)の一般薬理作用（第2報）−呼吸・循環器系に及ぼす影響 ; 加藤仁, 高田芳伸, 栗原順一, 渡邊直子, 鈴木義裕, 中村亨 : 薬理と治療 22(Suppl.3) S685−S691 (1994) | ||
38. |
Effects of benidipine hydrochloride on contractions induxed by some contractile agents in isolated cerebral and mesenteric arteries of dogs ; Suzuki, S., Uegomori, T., Ozaki, S., Takata, Y. and Kato, H.: Biol. Pharm. Bull. 18(4) 507−513 (1996) | ||
39. |
Possible involvement of both N- and L-type voltage-dependent Ca channels in adrenergic neurotransmission of canine saphenous veins in low Ca2+ plus tetraethylammonium ; Takata, Y., Ozawa, J. and Kato, H.: Naunyn-Schmiedeberg's Arch. Pharmacol. 346(4) 419−424 (1992) | ||
40. |
Influence of transient global cerebral ischemia on the facilitatory modulation of the vagal baroreflex in dogs ; Kurihara, J., Tamaoki, S. and Kato, H.: Jpn. J. Pharmacol. 63(2) 227-233 (1993) | ||
41. |
Blockade of alpha2-adrenoceptors protects the vagal baroreflex system from transient global cerebral ischemia in dogs ; Kurihara, J., Tamaoki, S. and Kato, H.: Eur. J. Pharmacol. 240(1) 73-76 (1993) | ||
42. |
Protection by nicorandil against the dysfunction of the central vagal baroreflex system following transient global ischaemia in dogs ; Kurihara, J., Ochiai, N. and Kato, H.: Br. J. Pharmacol. 109(4) 1263-1267 (1993) |
||
43. |
Possible involvement of ATP-sensitive K+ channels in the inhibition of rat central adrenergic neurotransmission under hypoxia ; Takata, Y., Shimada, F. and Kato, H.: Jpn. J. Pharmacol. 62(3) 279−287 (1993) | ||
44. |
Differential effects of diazoxide, cromakalim and pinacidil on adrenergic neurotransmission and 86Rb+ efflux in rat brain cortical slices ; Takata, Y., Shimada, F. and Kato, H.: J. Pharmacol. Exp. Ther. 263(3) 1293−1301 (1992) |
||
45. |
Possible involvement of both N- and L-type voltage-dependent Ca channels in adrenergic neurotransmission of canine saphenous veins in low Ca2+ plus tetraethylammonium ; Takata, Y., Ozawa, J. and Kato, H.: Naunyn-Schmiedeberg's Arch. Pharmacol. 346(4) 419−424 (1992) | ||
|
著書リスト・その他 | ||
|
1.
|
第5章 心臓・血管系に作用する薬物 1. 心臓・血管系の生理，2. 心不全治療薬，3. 抗不整脈薬：坂本 謙司，パートナー薬理学 改訂第3版，pp. 163-199，石井 邦雄，栗原 順一，田中 芳夫 編集，南江堂 (2019) | ||
|
2.
|
はじめの一歩の薬理学 第2版：石井 邦雄，坂本 謙司，羊土社 （2020） | ||
|
3.
|
泌尿器系に作用する薬物：栗原順一, IE 薬理学改訂第４版, 第XII章, pp345-352, 粕谷豊ら監修, 南江堂 (2002) |
||
|
4.
|
骨粗鬆症の治療薬：栗原順一, IE 薬理学改訂第４版第XVI章, pp423-430, 粕谷豊ら監修, 南江堂 (2002) | ||
|
5.
|
冬眠と脳虚血耐性：栗原順一, 冬眠する哺乳類, pp295-296, 東京大学出版会 (2000) | ||
|
6.
|
局所麻酔薬の作用-モルモットを用いた実験-：栗原順一, 加藤仁, 薬理学実習の実際とデ-タの見方, pp133-136, 日本私立薬科大学協会薬理学関連教科検討委員会編, 南山堂 (1999) | ||
|
7.
|
Intracellular signal transduction in the postischemic brain : Wieloch, T., Hu, B.R., Boris-Moeler, F., Cardell, M., Kamme, F., Kurihara, J. and Sakata, K., Adv. Neurol., 71, 371-388 (1996) | ||
|
8.
|
血管の収縮・弛緩反応の測定法：高田芳伸, 栗原順一, 加藤仁, 生物薬科学実験講座14-臓器機能測定法?-, pp498-525, 広川書店 (1992) | ||
|
9.
|
薬理学小辞典(翻訳)：加藤仁, 高田芳伸, 栗原順一, 丸善 (1988) | ||
|
|
|||